Comera Life Sciences Holdings, Inc. (CMRA)

NASDAQ: CMRA · IEX Real-Time Price · USD
1.37
-0.04 (-2.84%)
At close: Jan 27, 2023, 3:59 PM
1.41
+0.04 (2.92%)
After-hours: Jan 27, 2023, 7:59 PM EST
-2.84%
Market Cap 30.50M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 22.27M
EPS (ttm) -6.08
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 238,710
Open 1.42
Previous Close 1.41
Day's Range 1.31 - 1.52
52-Week Range 1.11 - 15.30
Beta 0.98
Analysts n/a
Price Target n/a
Earnings Date Feb 9, 2023

About CMRA

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Scien... [Read more]

Industry Biotechnology
Sector Healthcare
CEO Mr. Jeffrey S. Hackman
Employees 11
Stock Exchange NASDAQ
Ticker Symbol CMRA
Full Company Profile

Financial Performance

Financial Statements

News

Comera Life Sciences to Present at 22nd Annual PepTalk Conference

WOBURN, Mass., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) (“Company” or “Comera”), a life sciences company developing a new generation of bio-innovative biolo...

2 weeks ago - GlobeNewsWire

Comera Life Sciences Closes $3.6 Million Private Placement Priced At-the-Market under Nasdaq Rules

WOBURN, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve...

3 weeks ago - GlobeNewsWire

Comera Life Sciences to Participate in the Benchmark Company's Upcoming Discovery One-on-One Investor Conference

WOBURN, Mass., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve...

2 months ago - GlobeNewsWire

Comera Life Sciences Reports Financial Results for Third Quarter 2022 and Business Highlights

– Extended and broadened its ongoing research collaboration with Regeneron, a leading U.S. biotechnology company –

2 months ago - GlobeNewsWire

Comera Life Sciences Announces Favorable Preclinical Results of Lead SQore Excipient in SEQURUS-2 Study

WOBURN, Mass., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve...

3 months ago - GlobeNewsWire

Comera Life Sciences Expands Woburn Operations

Elected Officials, Industry Leaders Celebrate Biotech Workforce Growth at Ribbon-Cutting Event

4 months ago - GlobeNewsWire

Insiders Are Buying Up Comera Life Sciences (CMRA) Stock. Here's Why.

Shares of Comera Life Sciences (NASDAQ: CMRA) are up by over 30% following a flurry of insider purchases. As the name suggests, Comera is a life sciences company that seeks to improve traditional int...

4 months ago - InvestorPlace

Comera Life Sciences Announces Up To $15 million Purchase Agreement with Arena Business Solutions

WOBURN, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) (“Company” or “Comera”), a life sciences company developing a new generation of bio-innovative biolo...

5 months ago - GlobeNewsWire

Comera Life Sciences Provides Business Highlights and Reports Financial Results for the Second Quarter 2022

WOBURN, Mass., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve...

6 months ago - GlobeNewsWire

Comera Life Sciences Announces Issuance of U.S. Patent for Proprietary Excipients in SQore Platform

WOBURN, Mass.--(BUSINESS WIRE)--Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, ...

7 months ago - Business Wire

Comera Life Sciences Appoints Michael Campbell as Executive Vice President and Chief Financial Officer

WOBURN, Mass.--(BUSINESS WIRE)--Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, ...

8 months ago - Business Wire

What's Going On With OTR Acquisition Stock Today?

OTR Acquisition Corp (NASDAQ: OTRA) shares are trading higher Wednesday after the company filed a Form 8-K with the U.S. Securities and Exchange Commision. The move appears to be related to the high n...

9 months ago - Benzinga

Why Is OTR Acquisition (OTRA) Stock Up Today?

The shares of OTR Acquisition are climbing after the SPAC's shareholders overwhelmingly approved a merger with Comera. The post Why Is OTR Acquisition (OTRA) Stock Up Today?

9 months ago - InvestorPlace

Comera Life Sciences Announces Research Collaboration with Top 10 Pharmaceutical Company to Develop Subcutaneous Formulation

WOBURN, Mass.--(BUSINESS WIRE)--Comera Life Sciences, Inc. (“Comera” or the “Company”), which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and...

9 months ago - Business Wire

Comera Life Sciences to Present at 18th Annual PEGS Boston Conference & Expo

WOBURN, Mass.--(BUSINESS WIRE)--Comera Life Sciences, Inc., which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announce...

9 months ago - Business Wire

Comera Life Sciences and Intas Pharmaceuticals Announce Research Collaboration

WOBURN, Mass. & AHMEDABAD, India--(BUSINESS WIRE)--Today, Comera Life Sciences, Inc. (“Comera” or the “Company”) and Intas Pharmaceuticals Ltd. (“Intas”) announced a research collaboration to develop ...

10 months ago - Business Wire

Comera Life Sciences and OTR Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business Combination

WOBURN, Mass. & MIAMI--(BUSINESS WIRE)--Comera Life Sciences, Inc. (“Comera”), which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenie...

10 months ago - Business Wire